TCGX Acquisition Corp. Class A TCGX 深 沪
等待开盘 11-05 09:30:00 美东时间
10.04
+0.010
+0.10%
华盛通- 最 高10.06
- 今 开10.05
- 成交量 5.41万股
- 最 低 10.02
- 昨 收 10.03
- 总市值 11.35万
- 52周最高 18.91
- 市盈率 静 --
- 换手率 0.48%
- 52周最低 9.90
- 委 比 -0.10%
- 总股本 1.13万
- 历史最高 18.91
- 量 比 1.09
- 振 幅 0.40%
- 历史最低 9.90
- 每 手 1
- 风险率 1.79%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TriGemX Bio And TCGX Acquisition File Form S-4; Expect To Close Combination In Q1 2027 And Trade On Nasdaq Under Ticker Symbol 'TGEM'
TriGemX Bio, Inc. ("TriGemX Bio"), a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition Corp. (NASDAQ:TCGX) ("TCGX"), a publicly listed special purpose acquisition company, today announced the confidential submission of a d...
11-02 19:21
TriGemX Bio To Go Public Through Merger With TCGX Acquisition, Plans Nasdaq Listing Under TGEM; Upon Closing, Combined Company Expected to Receive ~$246M Of Gross Proceeds
Transaction Includes Concurrent $160 million Private Investment in Public Equity (PIPE) Financing and Expected Gross Proceeds of Approximately $246 million TriGemX Bio, a biotechnology company focused on developing elismetrep, a potential first-in-class treatment for migraine, and TCGX Acquisition C...
10-19 19:07
TCGX Acquisition Corp. Class A Completes IPO and Placement
TCGX Acquisition Corp. Class A ( ($TCGX) ) has issued an announcement. On Augus...
08-13 05:21
首日收市｜Attovia Therapeutics收市劲升28.82%，最新总市值9.42亿美元
Attovia Therapeutics劲升28.82%，最新市值9.42亿美元；TCGX Acquisition (Stock-Only)大升7.50%，最新市值1.06亿美元；
08-06 06:00
